Notice of Extension to PAR-25-028 "Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)"

Notice Number:

NOT-HL-25-011

Key Dates

Release Date:

May 21, 2025

Related Announcements

December 11, 2024 - Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required). See NOFO PAR-25-028.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform applicants that effective immediately the National Heart, Lung, and Blood Institute (NHLBI) is extending PAR-25-028 “Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required" by one Council round.

The following text in bold and italics has been updated to reflect the extension:

Part 1. Overview Information

Key Dates

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS - New/Renewal/Resubmission/Revision, as allowed	Scientific Merit Review	Advisory Council Review	Earliest Start Date
February 11, 2025	March 11, 2025	May 11, 2025	July 2025	October 2025	December 2025
June 11, 2025	July 11, 2025	September 11, 2025	November 2025	January 2026	April 2026
October 10, 2025	November 10, 2025	January 12, 2026	March 2026	May 2026	July 2026

Expiration Date: January 12, 2026

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Division of Blood Diseases and Resources
Division of Blood Diseases and Resources, Clinical Trials
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-25-028

Division of Cardiovascular Sciences
Yves Rosenberg, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-1292
Email: [email protected]

Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-25-028

Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-25-028

Financial/Grants Management Contact(s)
Office of Grants Management
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: PAR-25-028